Fuzhou Maixin Biotech Co., Ltd. (doing business as MXB Biotechnologies), part of Beijing Strong Biotechnologies, Inc., is a Chinese company located in Fuzhou. The firm engages in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH. It was founded in 1993. Xiao Ya Wang is the current CEO of the firm. Fuzhou Maixin Biotech Co. Ltd. acquired Fuzhou Maixin Biotech Co., Ltd. on September 30, 2020 for $255.21 million.

Consiglio Nazionale delle Ricerche is the largest public research facility in Italy. Founded in 1923, it has worked in the past as a government consultant on research and as a funding fund for university research grants. Since 1989 the CNR is a research institution, with the mission of carrying out research projects, promoting innovation and competitiveness of the national industrial system, the internationalization of the national research system, and providing technologies and solutions to emerging needs in the public and private sectors. . Objectives that are achieved through a wealth of human resources that has over 8000 employees, half of which is represented by researchers and technologists. About 4,000 young researchers are involved in post-doctoral research activities in the laboratories of the Institute, while an important contribution comes from collaborations, including international ones, with researchers from universities and companies, thus strengthening the national research system.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

Suzhou Proda Biotechnology Co., Ltd., established on 2012-12-22, Business scope includes biomedicine,Health products,food,cosmetic,medical instruments,Non-hazardous chemical products,Research and development of sewage treatment technology,Technical cooperation,technical consulting,technology transfer;Sales:Non-hazardous chemical products,Class I medical device,cosmetic.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Zhutian Zhongke Technology Development Co., Ltd., established on 2021-11-05, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Conference and Exhibition Services;translation service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Zhutian Technology Group Co., Ltd., established on 2016-12-22, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Engineering and Technology Research and Experimental Development;Conference Services;design,make,acting,Place an ad;translation service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Yafei (Shanghai) Biomedical Technology Co., Ltd. is a Chinese company located in Shanghai that engages in research and development of biomedical technologies & products.

Shenzhen Botai Biomedical Technology Development Co., Ltd., established on 2009-12-09, Business scope includes general business items:Technology development of biological gene technology and products(Does not contain country-restricted items);Domestic Trade(law,Administrative regulations,Except for projects that are subject to approval prior to registration as determined by the State Council);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:

Beijing Zhongke Jianlan Group Co., Ltd., established on 2018-11-21, Business scope includes technical services,technology transfer,technology development,Technology Promotion,technical consulting;Medical Research and Experimental Development;Biochemical product technology research and development;Sales of chemical products(Free of Hazardous Chemicals),Instrumentation,Class I,Class II medical device,cosmetic;Technology development in the field of medical devices;Production of class Ι medical devices;software development;Internet of Things Technology Services;product design;Import and export,Technology Import and Export,Agent import and export;business management;marketing planning;Conference Services;Undertake exhibition and display activities;health management,Health Advisory(Except for medical treatment activities subject to approval);brand management,Branding;copyright agent;translation service;Internet information service;retail medicine;Sales of Class III Medical Devices;patent agency;Production of the second class,Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Internet information service;patent agency;Sales of Class III Medical Devices;retail medicine;Production of the second class,Class III medical devices.and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. It also focuses on researching small molecule oncology compounds with a biomarker-driven approach that targets genetic vulnerabilities in cancer cells to deliver new therapies for patients suffering from aggressive hematologic. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Beijing Zhiheng Technology Co., Ltd., established on 2017-01-16, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;buisness planning,design;Conference Services;design,make,acting,Place an ad;translation service.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Liaoning MEDI Biotechnology Co. Ltd. is a private company headquartered in Benxi, China. The firm manufactures surgical and medical instruments.

Part of Thermo Fisher Scientific, Inc., Dynal Biotech Beijing Ltd. is a Chinese company. The firm manufactures inorganic chemicals.

Shenzhen Kangjuzheng Pharmaceutical Technology Co., Ltd., established on 2011-08-10, Business scope includes general business items:Pharmaceutical R&D and technology transfer,Technical Services,technical consulting;Technical development and sales of biotechnology products,Technical Services,technology transfer;Sales of biological consumables;Class I medical device,Sales of laboratory equipment;Operating import and export business;Research and development of chemical products,Technology Transfer and Sales.(None of the above is legal,Administrative regulations,The State Council decides to specify items that require pre-approval and prohibition),The licensing program is:

Fuzhou Chuangfang Pharmaceutical Technology Co., Ltd., established on 2013-05-16, Business scope includes general items:Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Natural science research and experimental development;Import and export;Technology Import and Export;Import and export agency;Technical extension services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Pharmaceutical commissioned production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Drug retail;Drug Wholesale;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) (not in<Negative List for Foreign Investment Access>Business activities in areas where foreign investment is prohibited)

Part of Lunan Pharmaceutical Group Co., Ltd., Shandong New Time Pharmaceutical Co. Ltd. is a Chinese company located in Linyi that manufactures pharmaceutical products.

Guangdong Langyuan Biotechnology Co., Ltd., established on 2018-03-07, Business scope includes medical research and experimental development,and related product sales and technology transfer,Serve,consult;Wholesale and retail of cosmetics and hygiene products;Wholesale and retail of Class I medical devices,trade agent;Import and export;wholesale,retail,research and development:Food safety testing reagents and instruments,Pesticide and veterinary drug residue testing reagents and instruments,non-therapeutic biological material,Biological product(In addition to vaccines),Electrical Equipment,computer software;Biological Technology,Detection technology research and development and technology transfer. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)